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FluorescenceCationic amyloid ﬁbrils, including the Semen Enhancer of Virus Infection (SEVI), have recently been
described in human semen. Simple methods for quantitating these ﬁbrils are needed to improve our
understanding of their biological function. We performed high-throughput screening to identify mole-
cules that bind SEVI, and identiﬁed a small molecule (8E2), that ﬂuoresced brightly in the presence of
SEVI and other cationic ﬁbrils. 8E2 bound SEVI with almost 40-fold greater afﬁnity than thioﬂavin-T,
and could efﬁciently detect high molecular weight ﬁbrils in human seminal ﬂuid.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.Amyloid ﬁbrils have been identiﬁed in various disease states,1 as
well as in normal tissues, including seminal ﬂuid.2–4 Seminal amy-
loid ﬁbrils are formed by self-assembling cationic peptides, and
strongly enhance human immunodeﬁciency virus type 1 (HIV-1)
infection.2–4 Furthermore, the magnitude of HIV-1 infection
enhancement by individual semen samples is correlated with the
relative levels of these ﬁbrillogenic peptides.3,5–7 As a result, there
is interest in developing methods to rapidly detect and quantitate
amyloid ﬁbrils in semen and other samples—including SEVI.3,5,8,9
However, the quantitative detection of SEVI is challenging because
of its cationic charge, but also because it exists in a highly disor-
dered structure, when compared to other amyloid ﬁbrils.10–12
The reagent most widely used to detect amyloids is thioﬂavin-T
(ThT).13 However, ThT may be suboptimal for binding to cationic
ﬁbrils,14,15 and is also ill-suited for studies of the disruption of
amyloid ﬁbrils by EGCG (epigallocatechin-3-gallate) and relatedcompounds,12 since EGCG and ThT exhibit competitive binding
for SEVI and other amyloid ﬁbrils.16–19
We therefore set out to identify novel small molecules capable
of binding to the cationic seminal amyloid ﬁbril, SEVI. To do this,
we designed and optimized a high throughput assay to identify
small molecules that could bind to SEVI (see Supplementary data;
Fig. S1). We then used this assay to screen a targeted library of
polyaromatic compounds (Fig. S2). Several SEVI-binding small
molecules were identiﬁed (Fig. S3, Table S1), including a ben-
zo[4,5]-imidazo[1,2-a]pyridine derivative that ﬂuoresced brightly
in the presence of SEVI; designated 8E2 (Fig. 1).
8E2 exhibited a broad absorbance spectrum (from 400 to
450 nm) and a very strong ﬂuorescence emission maximum in
Figure 3. 8E2 ﬂuorescence is ﬁbril speciﬁc. ThT or 8E2 (50 lM) were incubated
with monomeric PAP248–286 peptide or SEVI ﬁbrils (25 lM). Fluorescence intensity
was measured at excitation 465 nm, emission 535 nm. Background ﬂuorescence
intensity values were subtracted from experimental data. Data represent results
from three independent experiments performed in triplicate; error bars denote the
SEM.
Figure 4. ThT exhibits reduced ﬂuoresence in the presence of cationic amyloid
ﬁbrils, while 8E2 does not. ThT or 8E2 (50 lM) were combined with 25 lM of SEVI,
SEVI-Ala, Ab42, or Ab42+ ﬁbrils. Fluorescence intensities were measured at
excitation 465 nm, emission 535 nm. Background ﬂuorescence intensity values
were subtracted from experimental data. Data represent results from three
independent experiments performed in triplicate; error bars denote the standard
error of the mean.
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presence of SEVI ﬁbrils, and not in presence of the monomeric
PAP248286 peptide (Fig. 3). The molar extinction coefﬁcient (e) of
8E2 was roughly twice that of ThT when compared at their respec-
tive excitation absorbances, indicating its ability to absorb light
more efﬁciently than ThT. The efﬁciency of ﬂuorescence process
was measured by the quantum yield (U) calculations. 8E2 exhib-
ited considerably higher quantum yield compared to ThT (see Ta-
bles S2 and S3).
8E2’s ﬂuorescence properties were also evaluated in the pres-
ence of other amyloid ﬁbrils, including matched pairs of ﬁbrils that
were designed to differ in their overall charge, but only minimally
in their amino acid composition. For this purpose, we used SEVI
(formed from the cationic PAP248286 peptide) and SEVI-Ala
(formed from a non-cationic derivative of this peptide7). We also
used ﬁbrils formed from Ab42 and from a cationic derivative of this
peptide (Ab42+; see Supplementary data). We then compared the
peak ﬂuorescence for 8E2 and ThT in the presence of these ﬁbrils.
8E2 ﬂuoresced much more strongly than ThT in the presence of
the cationic amyloids (SEVI and Ab42+; Fig. 4). Consistent with this,
the disassociation constant (Kd) for binding of 8E2 to SEVI was
approximately 40-fold lower than the Kd for ThT (Table 1; Figs. S4
and S5). In contrast, the Kd of 8E2 for SEVI-Ala was only six-fold
higher than for ThT (Table 1; Figs. S4 and S5). We tentatively attri-
bute this to charge–charge repulsion between the quaternary het-
erocyclic nitrogen on ThT and the positively charged surface
cationic ﬁbrils.14,15 However, it is possible that other factors may
also play a role, since 8E2 and ThT exhibited similar Kd’s for Ab42
ﬁbrils and their cationic Ab42+ counterparts (Table 1).
Since ThT and 8E2 have quite divergent Kd’s for binding to var-
ious amyloid ﬁbrils, we wondered whether the two molecules
might bind ﬁbrils via different mechanisms. To test this, we per-
formed a binding competition experiment. To do this, we incu-
bated SEVI (5 lM) with 8E2 (0.25 lM) and ThT (80 lM), and
measured the peak of ﬂuorescence intensity for each molecule un-
der these conditions (Fig. 5). The experimentally observed peak of
ﬂuorescence intensity was almost exactly equal to the sum of the
peaks of ﬂuorescence intensity for 8E2 and ThT alone (Fig. 5).
This shows that 8E2 binding to SEVI was not competed away,
even in the presence of a 320-fold molar excess of ThT, and
suggests that the two molecules bind SEVI in a distinct (and
non-competitive) manner.
We next wished to test if 8E2 could detect amyloid ﬁbrils in
seminal ﬂuid (SF). As a ﬁrst step, we examined the effect of viscos-
ity on 8E2 ﬂuorescence. This is important because (i) seminal ﬂuidFigure 2. The spectral properties of 8E2. Wavelength scanning analysis for 8E2
absorbance (red). 8E2 (1 lM) was also incubated in the presence (light blue) or
absence (dark blue) of SEVI (5 lM), and ﬂuorescent intensities were measured at
excitation 418 nm. Error bars represent the standard error of the mean (SEM) from
one experiment performed in triplicate.
Table 1
Dissociation constants (Kd) for binding of 8E2 and ThT to SEVI, SEVI-Ala, Ab42+, Ab42
(5 lM) ﬁbrils
SEVI (lM) SEVI-Ala (lM) Ab42+ (lM) Ab42 (lM)
8E2 1.10 ± 0.09 1.61 ± 0.282 4.52 ± 0.753 2.60 ± 0.034
ThT 42.5 ± 4.2 0.246 ± 0.011 6.49 ± 1.78 1.83 ± 0.091
Kd data were determined by plotting the reciprocal of the ﬂuorescence maximum
(Fmax) versus the reciprocal of the concentration of the probe. The x-intercepts were
extrapolated from the linear regression and the negative reciprocal was taken
yielding the apparent Kd. Data were reported as an average of a triplicate, and error
was the standard error of the mean.is viscous, and (ii) ‘molecular rotor’ dyes such as ThT ﬂuoresce
strongly in viscous solutions that impede their rotation.20
ThT and 8E2 ﬂuorescence was sharply increased in the presence
of high concentrations of glycerol, but not in solutions containing
625% glycerol (Fig. S6). Thus, we diluted SF samples in Dulbecco’s
phosphate-buffered saline (DPBS), to a ﬁnal concentration of 10%,
and then examined 8E2 (and ThT) ﬂuorescence. A pooled SF stock
Figure 5. 8E2 binding to SEVI is not competed away by excess ThT. Upper bars: 8E2
(0.25 lM) or ThT (80 lM) were mixed with SEVI (5 lM) and ﬂuorescence was then
measured, as described (Fig. 4). Immediately below these bars is the predicted
combined ﬂuorescence of 8E2 (0.25 lM) and ThT (80 lM) in the presence of 5 lM
SEVI, assuming that the two compounds were to bind independently to SEVI –
without interference or synergy. The lowest bar shows the experimentally
determined ﬂuorescence value after SEVI (5 lM) was (i) pre-incubated with 8E2
(0.25 lM), and (ii) a 320-fold molar excess of ThT (80 lM) was subsequently added.
It can be readily appreciated that the experimentally determined ﬂuorescence is
almost identical to the ‘additive prediction’. Thus, we conclude that 8E2 binding to
SEVI is not competed away by even a vast excess of ThT.
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an aliquot of this stock was subjected to ultraﬁltration to remove
high molecular weight ﬁbrils. ThT and 8E2 ﬂuorescence was high
in the pooled SF’ sample but much lower in the ‘pooled & ﬁltered
SF’ sample (Fig. 6A and B). Thus, ﬂuorescence of 8E2 (and ThT) inFigure 6. Detection of amyloid ﬁbrils in seminal ﬂuid using 8E2. (A, B) Equal volumes of 2
this sample was subjected to ultraﬁltration with a 100,000 molecular weight cutoff spin
was added back to the ﬁltered SF (‘pooled & ﬁltered SF, +SEVI’). 8E2 (panel A) or Th
concentration of 10% in DPBS), and ﬂuorescence intensity was measured (see Fig. 3). Resu
consistently three to four-fold higher than for ThT. Data represent triplicate measuremen
were diluted to a ﬁnal concentration of 10% in DPBS. 8E2 or ThT (50 lM) were then add
ﬂuorescence values was analyzed using a non-parametric Spearman rank correlation
(D) Increasing concentrations of SEVI ﬁbrils were added to ‘pooled and ﬁltered SF’, an
ﬂuorescence was linearly related to the concentration of SEVI in the sample, over a phys
linear regression ﬁt of the data (R2 = 0.99). Data represent mean values from one experiSF can be attributed to ﬁlterable, high-molecular weight material
(presumably ﬁbrils). In addition, when a physiologic concentration
of SEVI (35 lg/mL) was added back to the ﬁltered SF sample, robust
8E2 (and ThT) ﬂuorescence was restored (Fig. 6A and B).
Next, we analyzed 8E2 (and ThT) ﬂuorescence in a panel of
10% SF samples. The results (Fig. 5C) revealed a strong correla-
tion between ThT and 8E2 ﬂuorescence in the samples (p
<0.001; Spearman rank correlation test). This suggests that the
two dyes likely recognize similar aggregates in SF samples—with
8E2 consistently giving a stronger ﬂuorescence signal than ThT
(Fig. 5B).
Finally, increasing concentrations of SEVI ﬁbrils were added to
‘pooled & ﬁltered’ SF, and 8E2 ﬂuorescence was measured. The
intensity of 8E2 ﬂuorescence was linearly related to the concentra-
tion of SEVI in the sample, over a range of 0.28–70 lg/mL (i.e., a
physiologic concentration range) (Fig. 5D).
Human semen contains cationic amyloid ﬁbrils that have been
shown to dramatically increase HIV infection in vitro.2–4 The devel-
opment of simple, sensitive and quantitative methods for the
detection and quantitation of these ﬁbrils will be essential to
understanding their biologic signiﬁcance. Here, we identiﬁed a
benzo[4,5]-imidazo[1,2-a]pyridine derivative, designated 8E2, that
binds SEVI with a Kd that is approximately 40-fold lower than that
of ThT, and that also ﬂuoresces much more brightly than ThT in the
presence of cationic amyloid ﬁbrils (including SEVI). These ﬁndings
suggest that 8E2 and related compounds may represent an useful
class of amyloid-binding molecules, for quantitating cationic ﬁbrils
in biological specimens. Experiments are also underway to assess
their utility in other amyloid-speciﬁc applications.1 seminal ﬂuid samples were combined to produce a pool (‘pooled SF’). An aliquot of
ﬁlter (‘pooled & ﬁltered SF’). Finally, a physiologic concentration of SEVI (35 lg/mL)
T (panel B) (50 lM) were then added to these samples (after dilution to a ﬁnal
lts for 8E2 are shown in panel A, and results for ThT in panel B; 8E2 ﬂuorescence was
ts from a single experiment; error bars denote SEM. (C) The 21 individual SF samples
ed, and ﬂuorescence intensity was measured. The correlation between ThT and 8E2
test (p <0.0001). The line shows a linear regression ﬁt of the data (R2 = 0.75).
d 8E2 ﬂuorescence was then measured. The data show that the intensity of 8E2
iologic concentration range (0.28–70 lg/mL of SEVI). The line in this panel shows a
ment performed in triplicate; error bars denote the standard error of the mean.
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Supplementary data
Supplementary data (experimental details, high-throughput
screening data, chemical structures and FP assay data, molar
extinction coefﬁcient calculations, quantum yield calculations,
ﬂuorescence of 8E2 derivatives with SEVI, binding curves of 8E2
and ThT with ﬁbrils, plots for calculating dissociation constants,
ThT and 8E2 ﬂuorescence in highly viscous solutions, and an anal-
ysis of 8E2 ﬂuorescence in samples containing varying levels of
SEVI.) associated with this article can be found, in the online ver-
sion, at http://dx.doi.org/10.1016/j.bmcl.2013.06.097.
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